Literature DB >> 11751735

Pressure-altering agents affect central aortic pressures more than is apparent from upper limb measurements in hypertensive patients: the role of arterial wave reflections.

C Vlachopoulos1, K Hirata, M F O'Rourke.   

Abstract

The pressure pulse does not have the same amplitude in central and peripheral arteries, but it is amplified toward the periphery; the degree of this amplification depends principally on wave reflection. Despite the conventional clinical and epidemiological focus on peripheral pressures, the most physiologically relevant pressures for both cardiac and vascular effects are central pressures. The reflected wave contributes differently in the configuration of the peripheral and central pressure waveform. Therefore, we hypothesized that agents that alter wave reflections could have an unequal effect on central and peripheral pressures in hypertensive patients. Thus, the effect of caffeine was investigated in 10 hypertensive subjects according to a randomized, placebo-controlled, double-blind, crossover design. Central aortic pressures and wave reflection were assessed with applanation tonometry and pulse wave analysis. After caffeine, augmentation index and augmented pressure increased by 4.6%, (P<0.005) and 5.7 mm Hg (P<0.001), respectively, indicating increased effect of wave reflection from the periphery. The increase in aortic systolic pressure was greater compared with that in radial artery pressure at 30 minutes (25%) and marginally greater at 60 minutes (21%). Furthermore, the increase in aortic pulse pressure was greater at 30 and 60 minutes (34% and 40%, respectively). The intensified reflected wave after caffeine was largely responsible for the disparate effect between central and peripheral pressures by boosting the peak of the central and not of the peripheral waveform. This study shows that pressure-altering agents might affect central pressures more than is apparent from the corresponding upper limb values because of the concomitant changes in wave reflection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751735     DOI: 10.1161/hy1201.098767

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  12 in total

Review 1.  Clinical appraisal of arterial stiffness: the Argonauts in front of the Golden Fleece.

Authors:  C Vlachopoulos; K Aznaouridis; C Stefanadis
Journal:  Heart       Date:  2005-12-09       Impact factor: 5.994

2.  Pulse pressure and adverse outcomes in women: a report from the Women's Ischemia Syndrome Evaluation (WISE).

Authors:  R David Anderson; B Clay Sizemore; Genevieve M Barrow; B Delia Johnson; C Noel Bairey Merz; George Sopko; Gregory O von Mering; Eileen M Handberg; Wilmer W Nichols; Carl J Pepine
Journal:  Am J Hypertens       Date:  2008-09-18       Impact factor: 2.689

3.  Nonlinear dynamics of blood pressure variability after caffeine consumption.

Authors:  Theodore G Papaioannou; Charalambos Vlachopoulos; Nikolaos Ioakeimidis; Nikolaos Alexopoulos; Christodoulos Stefanadis
Journal:  Clin Med Res       Date:  2006-06

4.  Adalimumab decreases aortic stiffness independently of its effect in disease activity in patients with rheumatoid arthritis.

Authors:  Dimitrios Vassilopoulos; Athanasios Gravos; Charalambos Vlachopoulos; Anna Kandili; Nikolaos Ioakeimidis; Dimitrios Pectasides; Christodoulos Stefanadis
Journal:  Clin Rheumatol       Date:  2014-06-15       Impact factor: 2.980

Review 5.  Therapeutic modification of arterial stiffness: An update and comprehensive review.

Authors:  Ching-Fen Wu; Pang-Yen Liu; Tsung-Jui Wu; Yuan Hung; Shih-Ping Yang; Gen-Min Lin
Journal:  World J Cardiol       Date:  2015-11-26

6.  Acute and long-term hemodynamic effects of sesame oil consumption in hypertensive men.

Authors:  Kalliopi Karatzi; Kimon Stamatelopoulos; Marita Lykka; Pigi Mantzouratou; Sofia Skalidi; Efstathios Manios; George Georgiopoulos; Nikolaos Zakopoulos; Christos Papamichael; Labros S Sidossis
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-24       Impact factor: 3.738

7.  Beneficial effect of angiotensin II type 1 receptor blocker antihypertensive treatment on arterial stiffness: the role of smoking.

Authors:  Gregory P Vyssoulis; Eva A Karpanou; Stella-Maria G Kyvelou; Dionysios N Adamopoulos; George C Antonakoudis; Alexandros D Deligeorgis; Dennis V Cokkinos; Christodoulos I Stefanadis
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-03       Impact factor: 3.738

8.  Insight into the 24-hour ambulatory central blood pressure in adolescents and young adults.

Authors:  Angeliki Ntineri; Anastasios Kollias; Maria Elena Zeniodi; Andriani Vazeou; Alexandra Soldatou; George S Stergiou
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-19       Impact factor: 3.738

9.  Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.

Authors:  G D Radchenko; Y M Sirenko; S M Kushnir; O O Torbas; A S Dobrokhod
Journal:  Vasc Health Risk Manag       Date:  2013-09-27

10.  Cardiovascular safety of anagrelide in healthy subjects: effects of caffeine and food intake on pharmacokinetics and adverse reactions.

Authors:  Manuel Martínez-Sellés; Tomás Datino; Lourdes Figueiras-Graillet; Joubert G Gama; Christopher Jones; Richard Franklin; Francisco Fernández-Avilés
Journal:  Clin Drug Investig       Date:  2013-01       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.